Skip to main content

Enabling the European Nanomedicine Area until 2020

Objective

Nanotechnology applied to medical applications, Nanomedicine, is one of the most important emerging areas of health research and is understood to be the most promising out of the six KETs, for innovative devices and materials for personalised, targeted and regenerative medicine. However, due to the complexity of technologies and medical application areas Nanomedicine requires many different so far independent stakeholders from academia, industry and regulatory bodies. Due to the diversity of stakeholders the partners of this project will initiate a strong coordination and support action to build a pertinent European Nanomedicine community involving all key players necessary to define the resources, gaps and needs for development and implementation of nanomedical research into marketable innovations to be used by doctors for the benefit of patients. The implementation concepts will also target the initiation of Public Private Partnerships for the creation of novel infrastructures and innovative funding programmes.
Nanomedicine research is growing fast in many countries. Therefore, the project consortium will initiate international collaborations in the Nanomedicine area, especially the coordination of international regulation of Nanomedicine products.
The partners involved in the project represent major European networks combining academia, industry, clinicians and public authorities. Based on this strong partnership and after integration of further national and European initiatives the output of this support action will be a strong, established partnership of relevant stakeholders in identified key areas of Nanomedicine with new concepts for translation of nanomedical innovations into clinical practice and efficient and transparent communication channels. This will make Nanomedicine an important contributor to the future European healthcare system with a beneficial impact on improved treatment for patients and on social challenges such as ageing population.

Call for proposal

FP7-HEALTH-2012-INNOVATION-1
See other projects for this call

Coordinator

VDI/VDE INNOVATION + TECHNIK GMBH
Address
Steinplatz 1
10623 Berlin
Germany

See on map

Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
Nicolas Gouze (Mr.)
EU contribution
€ 176 817,50

Participants (6)

EUROPAISCHE STIFTUNG FUR KLINISCHE NANOMEDIZIN
Switzerland
EU contribution
€ 89 880
Address
Alemannengasse 12
4016 Basel

See on map

Activity type
Other
Administrative Contact
Beat Löffler (Mr.)
INSTITUTO DE SALUD CARLOS III
Spain
EU contribution
€ 49 969
Address
Monforte De Lemos 5
28029 Madrid

See on map

Activity type
Research Organisations
Administrative Contact
Miguel Angel Cabo (Mr.)
GESELLSCHAFT FUR BIOANALYTIK MUNSTER EV
Germany
EU contribution
€ 39 590
Address
Mendelstrasse 11
48149 Munster

See on map

Activity type
Research Organisations
Administrative Contact
Klaus-Michael Weltring (Dr.)
NANOBIOTIX SA
France
EU contribution
€ 20 330
Address
Rue De Wattignies, Batiment B 60
75012 Paris

See on map

Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
Laurent Levy (Dr.)
FONDAZIONE DON CARLO GNOCCHI ONLUS
Italy
EU contribution
€ 44 993,50
Address
Piazzale Rodolfo Morandi 6
20148 Milano

See on map

Activity type
Research Organisations
Administrative Contact
Furio Gramatica (Dr.)
STIFTELSEN SINTEF
Norway
EU contribution
€ 78 067,20
Address
Strindveien 4
7034 Trondheim

See on map

Activity type
Research Organisations
Administrative Contact
Tove L. Hønstad (Mrs.)